Intelligent automation consultancy Tquila Automation has announced its acquisition of Element Blue, an intelligent automation company in the US healthcare market.
To fund the acquisition, Tquila Automation raised Series A financing totalilng US$20m (£16.5m), led by Delta-v Capital, with additional participation from Tquila and Momentum Partners.
Houston-based Element Blue’s solutions are designed to streamline patient access, referrals and the revenue cycle from providers to payers.
With Tquila Automation’s intelligent automation capabilities, the combined business should better support enterprise-level customers across healthcare and other industries.
Tom Abbott, Tquila Automation CEO and co-founder, said: “The acquisition of Element Blue realises our strategy of building industry specialist capability across the USA and Europe.
“Every sector has very specific needs when it comes to intelligent automation, and healthcare is no exception.
“It brings together two specialists to deliver enhanced value and a broader range of capabilities for clients. We’re stronger as one.”
Element Blue’s team of 65 will continue to work under its current name as part of the Tquila Automation business.
Earlier this year, Tquila Automation announced that it has relocated its European HQ to Moor Place in the City of London’s financial district.
Since June 2023, the office has acted as the company’s central hub for advisory, products, and sales teams that support clients across the UK, Ireland and Northern Europe.
